Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
According to a recent study published in the American Journal of Infection Control, 71 percent of reusable medical scopes tested positive for bacteria.
As a result of the implementation of varying electronic health record (EHR) systems, 36 percent of medical record administrators struggle with the exchange of patient health records with providers with differing EHR platforms. Findings were published April 20 in a report by Black Book Market Research.
TriHealth, a Cincinnati-based health system, has announced a $10 million-dollar investment to implement the IBM Watson Health’s Enterprise Imaging Portfolio.
Scientists at Cedars-Sinai have recreated neurons in a dish to better analyze the brain’s role in obesity and to improve the development of personalized treatment. Findings were published in Cell Stem Cell.
A new type of "smart" socks could improve the diagnosis and treatment of remote patients by providing physiotherapists with real-time information on lower body movements.
